Abeona Therapeutics Stock Price Patterns
| ABEO Stock | USD 5.08 0.25 5.18% |
Momentum 51
Impartial
Oversold | Overbought |
Using Abeona Therapeutics hype-based prediction, you can estimate the value of Abeona Therapeutics from the perspective of Abeona Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Abeona Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Abeona because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Abeona Therapeutics after-hype prediction price | USD 5.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Abeona Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abeona Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abeona Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Abeona Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Abeona Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Abeona Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Abeona Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Abeona Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Abeona Therapeutics' historical news coverage. Abeona Therapeutics' after-hype downside and upside margins for the prediction period are 0.93 and 9.23, respectively. We have considered Abeona Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Abeona Therapeutics is relatively risky at this time. Analysis and calculation of next after-hype price of Abeona Therapeutics is based on 3 months time horizon.
Abeona Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Abeona Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abeona Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Abeona Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.17 | 4.15 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
5.08 | 5.08 | 0.00 |
|
Abeona Therapeutics Hype Timeline
Abeona Therapeutics is presently traded for 5.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Abeona is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.17%. %. The volatility of related hype on Abeona Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 5.08. About 68.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.62. Some equities with similar Price to Book (P/B) outperform the market in the long run. Abeona Therapeutics had not issued any dividends in recent years. The entity had 1:25 split on the 5th of July 2022. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Abeona Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.Abeona Therapeutics Related Hype Analysis
Having access to credible news sources related to Abeona Therapeutics' direct competition is more important than ever and may enhance your ability to predict Abeona Therapeutics' future price movements. Getting to know how Abeona Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Abeona Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TNYA | Tenaya Therapeutics | 0.00 | 0 per month | 0.00 | (0.10) | 9.02 | (8.57) | 49.22 | |
| ELDN | Eledon Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.10) | 8.97 | (7.95) | 51.49 | |
| PBYI | Puma Biotechnology | 0.00 | 0 per month | 4.24 | 0.09 | 4.39 | (3.81) | 43.28 | |
| HUMA | Humacyte | 0.00 | 0 per month | 0.00 | (0.15) | 8.16 | (8.13) | 20.54 | |
| VYGR | Voyager Therapeutics | 0.00 | 0 per month | 0.00 | (0.08) | 4.58 | (5.23) | 19.71 | |
| ARCT | Arcturus Therapeutics Holdings | 0.00 | 0 per month | 0.00 | (0.11) | 6.10 | (6.72) | 15.98 | |
| FHTX | Foghorn Therapeutics | 0.00 | 0 per month | 4.33 | 0.09 | 9.16 | (5.56) | 31.12 | |
| SGMT | Sagimet Biosciences Series | 0.00 | 0 per month | 0.00 | (0.17) | 5.37 | (8.25) | 23.02 | |
| ASMB | Assembly Biosciences | 0.00 | 0 per month | 0.00 | (0.08) | 5.85 | (6.65) | 18.53 |
Abeona Therapeutics Additional Predictive Modules
Most predictive techniques to examine Abeona price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Abeona using various technical indicators. When you analyze Abeona charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Abeona Therapeutics Predictive Indicators
The successful prediction of Abeona Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Abeona Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Abeona Therapeutics based on analysis of Abeona Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Abeona Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Abeona Therapeutics's related companies.
Pair Trading with Abeona Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abeona Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Abeona Stock
The ability to find closely correlated positions to Abeona Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abeona Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abeona Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abeona Therapeutics to buy it.
The correlation of Abeona Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abeona Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Abeona Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Stock sector continue expanding? Could Abeona diversify its offerings? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Abeona Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Abeona Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Abeona Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Abeona Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Abeona Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Abeona Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Abeona Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.